Brief: Neuland Labs Says Outlook Dampening For Fluoroquinolones In Regulated Markets
14/11/2019 10:42
Nov 14 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* WHILE WE CONTINUE TO SEE GROWTH IN KEY PRODUCTS, THERE IS
A
DAMPENING IN OUTLOOK FOR FLUOROQUINOLONES IN REGULATED MARKETS
Source text for Eikon: ID:nBSE9X6vD5
Further company coverage: NEUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees